Summary:
- Phase 2/3 Randomized, Double-Blind Placebo controlled Depression Study to evaluate the safety and efficacy of an investigational Antidepressant Medication.
Criteria:- Be actively Depressed over the past 6 weeks.
- Be willing to take an investigational medication.
- Be willing to add on a medication to current treatment or stop some psychiatric medications.
- Age between 18-74
- Main diagnosis or source of treatment is Depression.
- Be willing to travel to Oceanside for in-person study visits.
Qualified Participants May Receive:
- Compensation up to $1,000 for study related time and travel.
- Study related care and medication at no cost.
- No Insurance required to participate.